Literature DB >> 9804733

Aspirin prophylaxis for vascular disease. Knowledge needs to be used in clinical situations.

D Fitzmaurice, C P Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9804733      PMCID： PMC1114217          DOI： 10.1136/bmj.317.7168.1318a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-04-25

Review 2.  North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.

Authors:  M Eccles; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-05-02

Review 3.  Developing clinically valid practice guidelines.

Authors:  J Grimshaw; M Eccles; I Russell
Journal:  J Eval Clin Pract       Date:  1995-09       Impact factor: 2.431

4.  Carotid endarterectomy: an underutilized means of stroke prevention.

Authors:  C D Irvine; A H Davies; P M Lamont; R N Baird
Journal:  Br J Surg       Date:  1996-10       Impact factor: 6.939

5.  MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

6.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

7.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

8.  Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group.

Authors:  S Juul-Möller; N Edvardsson; B Jahnmatz; A Rosén; S Sørensen; R Omblus
Journal:  Lancet       Date:  1992-12-12       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.